UNBX — Unity Biotechnology Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force
Brief: Unity Biotechnology Q1 Operating Income USD -6.891 Million
U.S. STOCKS ON THE MOVE-Dutch Bros, Affirm, Mattel
U.S. STOCKS ON THE MOVE-FedEx, Generac, Steel Dynamics
Unity Biotechnology falls as eye disease treatment fails in mid-stage trial
Brief: UNITY Biotechnology appoints Yehia Hashad to its board
Brief: Unity Biotechnology Q4 Operating Income USD -9.991 Million
Brief: Unity Biotechnology Appoints Federico Grossi As Chief Medical Officer
Brief: Unity Biotechnology Q3 Operating Income USD -6.602 Million
Unity Biotechnology Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Unity Biotechnology Q2 Operating Income USD -6.979 Million
Unity Biotechnology Inc Expected To Post A Loss Of 46 Cents A Share: Earnings Preview
Unity Biotechnology Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: Unity Biotechnology Q1 Operating Income USD -7.599 Million
Unity Biotechnology Inc Expected To Post A Loss Of 53 Cents A Share: Earnings Preview
Unity Biotechnology Inc Reports Results For The Quarter Ended In December: Earnings Summary